Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects

被引:36
作者
Al-Hamodi, Zaid [1 ]
Ismail, Ikram S. [2 ]
Saif-Ali, Riyadh [1 ,3 ]
Ahmed, Khaled A. [4 ]
Muniandy, Sekaran [1 ]
机构
[1] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur 50603, Malaysia
[2] Univ Malaya, Med Ctr, Dept Med, Kuala Lumpur 50603, Malaysia
[3] Sanaa Univ, Fac Med, Dept Biochem, Sanaa, Yemen
[4] Ibb Univ, Fac Dent, Ibb, Yemen
来源
CARDIOVASCULAR DIABETOLOGY | 2011年 / 10卷
关键词
CORONARY-HEART-DISEASE; INSULIN-RESISTANCE SYNDROME; MYOCARDIAL-INFARCTION; ARTERY-DISEASE; RISK-FACTORS; FIBRINOLYTIC SYSTEM; PREDICTIVE-VALUE; PLASMA; OBESITY; INFLAMMATION;
D O I
10.1186/1475-2840-10-23
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Increased plasma plasminogen activator inhibitor-1 (PAI-1) activity and decreased tissue plasminogen activator (tPA) activity could be considered a true component of the metabolic syndrome (MetS) associated with an increased risk of developing cardiovascular diseases (CVD) and fibrinolytic abnormalities. The aim of this study was to investigate the association of tPA and its inhibitor PAI-1 with type 2 diabetes (T2D) and MetS and interrelationship between PAI-1 and tPA activities and antigens in Malaysian T2D and normal subjects. Methods: The plasma activities and antigens of PAI-1 and tPA and the levels of the tPA/PAI-1 complex as well as serum insulin, parameter of the coronary risk panel and plasma glucose at fasting state were studied in 303 T2D subjects (227 with MetS and 76 without MetS), 131 normal non-diabetic non-metabolic subjects and 101 nondiabetic MetS subjects. Results: The PAI-1 activity was higher in subjects with T2D with MetS (P = 9.8 x 10(-19)) and non-diabetic subjects with MetS (P = 3.0 x 10(-15)), whereas the tPA activity was lower in T2D with MetS (P = 0.003) as compare to normal subjects. Plasma tPA antigen levels were higher in subjects with T2D with MetS (P = 8.9 x 10(-24)), T2D without MetS (P = 1.3 x 10(-13)) and non-diabetic MetS subjects (P = 0.002). The activity and antigen of PAI-1 in normal subjects were related to insulin resistance (P = 2.2 x 10(-4); 0.007). Additionally, the PAI-1 activity was associated with an increased waist circumference (P = 2.2 x 10(-4)) and decreased HDL-c (P = 0.005), whereas the tPA activity was associated with decreased FBG (P = 0.028). The highest correlation was between PAI-1 activity and its antigen (R-2 = 0.695, P = 1.1 x 10(-36)) in diabetic subjects. The tPA activity negatively correlated with its antigen (R-2 = -0.444, P = 7.7 x 10(-13)) in normal subjects and with the PAI-1 activity and antigen (R-2 = -0.319, P = 9.9 x 10(-12); R2 = -0.228, P = 3.4 x 10(-6)) in diabetic subjects. Conclusions: PAI-1 and tPA activities and antigens were associated with diabetes and MetS parameters in Malaysian subjects.
引用
收藏
页数:9
相关论文
共 63 条
  • [1] The metabolic syndrome - a new worldwide definition
    Alberti, KGMM
    Zimmet, P
    Shaw, J
    [J]. LANCET, 2005, 366 (9491) : 1059 - 1062
  • [2] Rasminogen activator inhibitor-1, adipose tissue and insulin resistance
    Alessi, Marie-Christine
    Poggi, Marjorie
    Juhan-Vague, Irene
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2007, 18 (03) : 240 - 245
  • [3] NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older
    Alexander, CM
    Landsman, PB
    Teutsch, SM
    Haffner, SM
    [J]. DIABETES, 2003, 52 (05) : 1210 - 1214
  • [4] Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease
    Anand, SS
    Yi, QL
    Gerstein, H
    Lonn, E
    Jacobs, R
    Vuksan, V
    Teo, K
    Davis, B
    Montague, P
    Yusuf, S
    [J]. CIRCULATION, 2003, 108 (04) : 420 - 425
  • [5] Relationship of activated partial thromboplastin time to coronary events and bleeding in patients with acute coronary syndromes who receive heparin
    Anand, SS
    Yusuf, S
    Pogue, J
    Ginsberg, JS
    Hirsh, J
    [J]. CIRCULATION, 2003, 107 (23) : 2884 - 2888
  • [6] Association of multiple risk factors and insulin resistance with increased prevalence of asymptomatic coronary artery disease by an electron-beam computed tomographic study
    Arad, Y
    Newstein, D
    Cadet, F
    Roth, M
    Guerci, AD
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (12) : 2051 - 2058
  • [7] Impact of Body Mass Index and the Metabolic Syndrome on the Risk of Cardiovascular Disease and Death in Middle-Aged Men
    Arnlov, Johan
    Ingelsson, Erik
    Sundstrom, Johan
    Lind, Lars
    [J]. CIRCULATION, 2010, 121 (02) : 230 - U88
  • [8] TISSUE-TYPE PLASMINOGEN-ACTIVATOR ANTIGEN AND PLASMINOGEN-ACTIVATOR INHIBITOR IN DIABETES-MELLITUS
    AUWERX, J
    BOUILLON, R
    COLLEN, D
    GEBOERS, J
    [J]. ARTERIOSCLEROSIS, 1988, 8 (01): : 68 - 72
  • [9] BAVENHOLM P, 1995, THROMB HAEMOSTASIS, V73, P568
  • [10] Carotid atherosclerosis and coronary heart disease in the metabolic syndrome - Prospective data from the Bruneck Study
    Bonora, E
    Kiechl, S
    Willeit, J
    Oberhollenzer, F
    Egger, G
    Bonadonna, RC
    Muggeo, M
    [J]. DIABETES CARE, 2003, 26 (04) : 1251 - 1257